TNF and ductal breast carcinoma in situ: The results presented in Figure 8a and in Table 3 demonstrate that there was a significant elevation in % TNFα-positive cells/patient in the IDC-with-relapse group when it was compared to DCIS and to the IDC-no-relapse groups, where p = 0.0008 for % TNFα-positive cells, and p = 0.0331 for TNFα score (as indicated in the legend to Table 3).